Process Evaluation of INN Prophylaxis Program for HIV Positive Patient in the ENARP Site
No Thumbnail Available
Date
2004-04
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Abeba Universty
Abstract
HIV infection is the greatest known risk factors for the development of active
tuberculosis in individuals latently infected with tuberculosis, and there is now strong evidence
for the efficacy of prophylaxis treatment in the prevention of TB in HIV infected individuals.
Implementation of Isoniazid PT in developing country presents several problems; therefore this
study tried to assess the IPT program implemented in the ENARP sites and its applicability in
other VCT centers. The objective of this study was to evaluating operational aspect of INH
prophylaxis program for Human immuno-deficiency virus positive patients in the ENARP sites.
A crossectional study supplemented with review of available cohort data was conducted. All HIV
positive cohort participants, in the two ENARP sites, were included
Of 132 HIV positive participants 61(21.6%) were selected for INH prophylaxis program based on
CD4 count who had less than 350 cell/mm3. Among 71(53.8%) participants who were not
included in the IPT program, 13(18.3%) died, 37(52.1%) subjects were excluded due to their CD4
count, 13(18.3%) due to recent TB treatment history and 5(7.04%) refused to participate in the
IPT program. TST were done to identify the most benefited with IPT, 44.3% were anergic and
26.2% were positive. Of 61 participant 57.4% were completed PT, 24.6% discontinued and
7(11.5%) subjects were on treatment during data collection. The study uptake looks appropriate
in that the risk of having TB increases with the CD4 count less than 350 cell/mm3, OR=1.12,95%
CI (1.06-1.28) .TST induration size had significant correlation with CD4 count using linear
regression model and Pearson correlation analysis. Except 9.8% the rest 84.4% got health care
support from the project to enhance adherence, 92.8% were agree on that ENARP staffs has good
patient approach. And 86.6% were appreciate the service given to them and recommend to others.
Of 61 participants 19(31.1%) missed scheduled appointment. Among 32 who completed
5(15.6%) of them missed ingesting daily pills only for a day. And INH metabolites test were
positive in 80.4% of study subjects. IPT doesn't have effect on CD4 count and weight using
Wilcoxon sign rank test. Ninety-three point seven of the cost of the program spent before the
patient starts PT. The benefit due to PT exceeded the cost of the program by 4.99 factors. Study
uptake looks appropriate, screening for active TB was performed as it was recommend by WHO.
Even though different methods used to select those most benefited, it needs further evaluation.
Adherence to treatment in the project favorably compares with other similar study. Therefore the
project has shown the feasibility of IPT in our context.
Description
Keywords
Process Evaluation of INN Prophylaxis Program